Elan Drug Delivery Inc.

Elan Corporation plc
875 Third Avenue
New York, 10022
United States
PH: 1 (353) 709 4000
Email: info@elan.com
Visit Elan Drug Delivery Inc. Website or Request Quote for Further Information

Primary Activity

Material Manufacturer

Company Background

Elan Corporation, plc is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases, and severe pain.

On June 5, 2006, Elan and Biogen Idec announced the approval of a supplemental Biologics License Application (sBLA) by the U.S. Food and Drug Administration (FDA) for the reintroduction of TYSABRI® (natalizumab) as a monotherapy treatment for relapsing forms of multiple sclerosis (MS) to slow the progression of disability and reduce the frequency of clinical relapses.